Filter by Knowledge Space:
Access to Advanced Health Institute
P7
Access to Advanced Health Institute
P2
Amneal Pharmaceuticals
Sunilkumar Patel
The Influence of Temperature and Humidity Control in Laboratory Settings on the Aerodynamic Particle Size Distribution of Soft Mist Inhalers
P4
Aptar Pharma
Goncalo Farias and Charles Cazzola
Optimization of a Multidose Nasal Actuator Targeting Olfactory Region Deposition
P4
Aptar Pharma
Pauline Faucard and Benedicte Grosjean
Leachables Assessment from a New Generation of pMDIs using Low Global Warming Potential Propellants and the Impact of Ethanol Filling
P1
Belhaven Biopharma
Brian Taubenheim
Pharmacokinetic Comparison of Nasal Delivered Dry Powdered Epinephrine to an Autoinjector (EpiPen®) in a Canine ModelP3
Bespak
Sabrina Falloon
Using Human Factors Studies to Optimize Nozzle Geometry for Patient Interaction in the Design Development of a Unit Dose Nasal SprayP9
Bespak
P15
Bespak
P10
CF PharmTech
P16
H&T Presspart
Mirjam Kobler
Advancing DPI Technology: A Modular Approach on Optimizing Capsule Movement for Improved Performance
P9
H&T Presspart
P9
Harro Höfliger
P3
Honeywell
Erik Boldt and Gregory Smith
Two Isn’t Always Better Than One: A Single-Actuation Salbutamol Sulfate Metered Dose Inhaler Using Low-GWP Propellant HFO-1234ze(E)P18
Hovione
Patricia Henriques and Dina Morais
Systemic Nasal Absorption of Amorphous Solid Dispersions: Supersaturating Systems for Fast Onset of Action of Poorly Soluble Drugs through the Nasal MucosaP16
Hovione
Maria Ines Lopes and Joao Pires
Drug Load Influence on Aerodynamic Properties of High Dosage DPIs: A Case Study of an Aminoglycoside Model DrugP24
Hovione
Alexandre Ribeiro
Differential Permeability of Dry Solid and Aqueous Suspensions of Fluticasone Propionate Through A549 Alveolar Epithelial Cells
P4
Hovione
Lidia Santos and Claudia Costa
Understanding Leucine Encapsulation in Dry Powder Inhaler Microparticles via Surface Characterization TechniquesP25
Iconovo
Måns Österberg Widerstrand and Jakob Samsøe
Novel Inhaled Anti-Viral Against SARS-CoV-2: Feasibility of Developing a Nanofitin Dry Powder Formulation for Pulmonary Delivery using the ICOone Single Dose Dry Powder InhalerP26
ImmuONE
Louis Scott and Ewelina Hoffman
High-Content Image Analysis for Phenotypic Characterization of Foamy Macrophage Responses of Alveolar Macrophages to Amiodarone
P2
InformiX Pharma
Parmesh Gajjar and Darragh Murnane
Novel Insight into the Microstructure of Fines-Only Formulations using X-ray Computed Tomography with Machine LearningP1
Inspiring
Barry Clements
The Impact of the Universal Spacer System on Efficiency and Reliability of Dose Delivery of Inhaled Nebulized AerosolsP2
IPAC-RS
Svetlana Lyapustina
Regulatory Topics in Nasal Product Development: Pediatrics and Reliability ExpectationsP13
IPAC-RS
Jolyon Mitchell
Laser Diffraction Size Analysis of Products for Nasal Inhalation: A Survey of Expert UsersP12
Johannes Gutenberg-Universität Mainz
Moritz Fleischhauer
Tuning the Aerosol Delivery of the Respimat® Soft Mist InhalerP8
Kindeva Drug Delivery
James Drake
Practical Considerations for Conducting Successful In Vitro Bioequivalence Studies on InhalersP1
Lonza
Sana Hosseini and Kimberly Shepard
Formulation of an Intranasal Dry Powder Vaccine Candidate for TuberculosisP1
Lonza
Neerja Zambare and Kimberly Shepard
Manufacturability of Intranasal Dry Powders Spray Dried from Aqueous SolutionsP8
Ludwig-Maximilians-University Munich
Katrin Wiebe and Simone Carneiro
Impact of Vibrating Mesh Nebulization on the Physicochemical Properties of mRNA and siRNA Lipid Nanoparticle FormulationsP6
M2M Pharmaceuticals
P28
Macquarie University
Chun Yuen Jerry Wong
Enhancing Nose-to-Brain Drug Delivery: A Comparative Study of Peptide Formulations Using a Multidose Nasal SprayP5
Medisch Spectrum Twente
Dumiana Chamaon and Martijn F. Grinovero
Validation of the RS01X™ Smart Inhaler in a Clinical SettingP11
Monash University
P6
Monash University
Daniel Duke and Lingzhe Rao
Manipulation of pMDI Spray Morphology via Orifice Length Variation with Propellants HFA134a, HFA227, HFA152a and HFO1234ze(E)P7
Monash University
P2
Monash University
Swetha Chowdary Vutlapalli and Daniel Duke
Measurement of Vapor Pressure and Viscosity of Ethanol in HFA134a, HFA152a, and HFO1234ze(E) Mixtures used in pMDIsP11
Nanopharm
Will Ganley and Nuria Manzano
Comparative Assessment of Plume Velocity in pMDI Solutions: A Study using Phase Doppler Anemometry and SprayView AnalysisP8
Nanopharm
P12
Orexo AB
Jonas Sävmarker
Spray Dried Amorphous Epinephrine Nasal Powder for the Acute Treatment of AnaphylaxisP6
Oz-UK Limited
Daniel Lewis
Case Studies on Reformulation of BDP MDIs using Low GWP Propellants HFO1234ze and HFA152aP14
PARI Pharma
Andrea Winzen and Martin Schlun
Aerosol Performance and Usability Evaluation of New Pediatric Facemasks for a Valved Holding ChamberP17
Proveris Scientific Corporation
Deborah Jones and Timothy Fallon
Inhalation and Exhalation Airflow Resistance of Valved Holding ChambersP4
Proveris Scientific Corporation
P5
Pulmotree Medical
Carolina Dantas
Examining User Breathing Patterns During Nebulization with a Guided Inhalation ManeuverP3
Purdue University
Kinnari Arte
Impact of L-leucine on Stability and Aerosol Performance of Dry Powder Protein FormulationsP4
Purdue University
Shruti Sawant
Liposomal Formulation Reduces Cell Uptake of Bacteriophage in a Lung Epithelial Cell ModelP3
Resyca
Nicolas Buchmann
Assessing the Variability of In Silico Lung Deposition Predictions When Inhaling from Soft Mist Inhalers with Various Air Flow ResistancesP7
RTI International
Sara Maloney Norcross
Physicochemical and Aerodynamic Stability of Spray Dried Tigecycline Inhalation Powder for the Treatment of Pulmonary Nontuberculous Mycobacterial InfectionsP5
Solvias
P10
St. John's University
Alec Diorio and Alan Watts
The Anti-Microbial Peptide, H1b, for Non-Small Cell Lung Cancer Treatment: Dry Powder Formulation Development And CharacterizationP6
The University of Texas at Austin
Varsha Nair and Rex Moore
Lipid-Based Spray Dried Microparticles of Monoclonal Antibodies for InhalationP7
The University of Texas at Austin
Mike Sandoval and Alan Watts
Drum Filling of Thin-Film Freeze-Dried Monoclonal Antibody Powders into a Nasal Spray SystemP10
The University of Texas at Austin
P8
Trudell Medical International
P12
U.S. Food & Drug Administration
P10
U.S. Food & Drug Administration
Steven Chopski
Novel Method for Aerodynamic Particle Size Distribution Measurements from Respimat® InhalersP5
U.S. Food & Drug Administration
Nicholas Holtgrewe
Development of an In Vitro Method for In Vivo Prediction of Regional Deposition of Nasal PowdersP11
U.S. Food & Drug Administration
P11
U.S. Food & Drug Administration
P9
Universidade Estadual de Campinas
Laura Oliveira Nascimento
Effects of Surfactant Coating on Levofloxacin-Loaded Nanoparticles: Impact on Physicochemical Properties and In Vitro Cell Viability of Pulmonary Cells P4
Universidade Estadual de Campinas
Victoria Soares Soeiro
Enhancing Polymeric Nanodispersions for Improved Doxycycline Efficacy Against Lung Pathogen BiofilmsP5
University of Alabama at Birmingham
P13
University of Bristol
P5
University of Hong Kong
P14
University of Michigan
P7
University of Michigan
P15
University of Oklahoma
Alexa Beathard
Aerosol Performance of OHet72 Nanosuspensions Nebulized into a Custom-Made Nose-Only Dosing ChamberP6
University of Parma
Francesca Buttini
Comparing Carbon Emissions for Three Dry Powder Inhaler TechnologiesP18
University of Parma
Francesca Buttini
Effect of Ethanol Content and Actuator Orifice Diameter on the Performance of Salbutamol Sulfate pMDI Suspensions in HFO1234ze(E)P2
University of Parma
P17
University of Sydney
P14
Upperton Pharma Solutions
P15
Vast Therapeutics
P8
Vectura
P6
Virginia Commonwealth University
P9
Virginia Commonwealth University
Caleb Dalton
Pharmaceutical Aerosol Deposition in a Stainless-Steel Version of the VCU Mouth-Throat ModelsP7
Virginia Commonwealth University
P19
Virginia Commonwealth University
Victoria Garcia
Locally Administered Gemcitabine Chemotherapy for the Treatment of Osteosarcoma Lung MetastasesP10
Virginia Commonwealth University
P20
Virginia Commonwealth University
Rudra Pangeni
Efficient Delivery of Powder Aerosol to the Lungs of Small Animals with a New Air-Jet Dry Powder InsufflatorP21
Virginia Commonwealth University
Surendra Poudel
In Vivo Efficacy of Tobramycin Excipient Enhanced Growth Dry Powder Aerosol in Pseudomonas Aeruginosa Lung Infection ModelP22
Virginia Commonwealth University
Masahiro Sakagami
A Novel Hybrid Molecule of Melatonin and Curcumin: In Vivo Therapeutic Intervention in the Rat Model of Lung Fibrosis with Local Lung DeliveryP1
Virginia Commonwealth University
P8
Woolcock Institute of Medical Research
P12
